XML 18 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
CONDENSED STATEMENTS OF CONSOLIDATED STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Retained Deficit
Currency Translation Adjustment
Pensions, Net of Tax
Loss on Derivatives, Net of Tax
Noncontrolling Interests
Balance at beginning of period at Mar. 31, 2017 $ 206,710 $ 472,349 $ (208,784) $ (22,293) $ (36,654) $ (1,100) $ 3,192
Statement of Consolidated Stockholders' Equity              
Net (loss) income (32,633)   (32,543)       (90)
Stock-based compensation 291 291          
Other comprehensive income (loss), net of tax 3,639     3,742 459 (562)  
Balance at end of period at Jun. 30, 2017 178,007 472,640 (241,327) (18,551) (36,195) (1,662) 3,102
Balance at beginning of period at Mar. 31, 2017 206,710 472,349 (208,784) (22,293) (36,654) (1,100) 3,192
Statement of Consolidated Stockholders' Equity              
Net (loss) income 56,647            
Other comprehensive income (loss), net of tax 8,294            
Balance at end of period at Dec. 31, 2017 272,722 473,156 (151,848) (15,476) (35,278) (999) 3,167
Balance at beginning of period at Jun. 30, 2017 178,007 472,640 (241,327) (18,551) (36,195) (1,662) 3,102
Statement of Consolidated Stockholders' Equity              
Net (loss) income 956   1,024       (68)
Restricted stock surrender (2) (2)          
Stock-based compensation 253 253          
Other comprehensive income (loss), net of tax 2,879     2,349 459 71  
Balance at end of period at Sep. 30, 2017 182,092 472,892 (240,304) (16,202) (35,736) (1,591) 3,033
Statement of Consolidated Stockholders' Equity              
Net (loss) income 88,326   88,456       (130)
Restricted stock surrender (6) (6)          
Stock-based compensation 270 270          
Purchase of investment in subsidiary 264           264
Other comprehensive income (loss), net of tax 1,776     726 458 592  
Balance at end of period at Dec. 31, 2017 272,722 473,156 (151,848) (15,476) (35,278) (999) 3,167
Balance at beginning of period at Mar. 31, 2018 282,828 473,476 (156,348) (12,682) (32,580) 0 10,962
Statement of Consolidated Stockholders' Equity              
Net (loss) income (1,413)   (759)       (654)
Stock-based compensation 295 295          
Purchase of investment in subsidiary 5,531           5,531
Other comprehensive income (loss), net of tax (6,441)     (5,136) 366 (1,496) (175)
Balance at end of period at Jun. 30, 2018 280,800 473,771 (157,107) (17,818) (32,214) (1,496) 15,664
Balance at beginning of period at Mar. 31, 2018 282,828 473,476 (156,348) (12,682) (32,580) 0 10,962
Statement of Consolidated Stockholders' Equity              
Net (loss) income (61,256)            
Other comprehensive income (loss), net of tax (9,473)            
Balance at end of period at Dec. 31, 2018 218,367 474,603 (213,905) (19,862) (35,049) (2,307) 14,887
Balance at beginning of period at Jun. 30, 2018 280,800 473,771 (157,107) (17,818) (32,214) (1,496) 15,664
Statement of Consolidated Stockholders' Equity              
Net (loss) income (54,842)   (54,634)       (208)
Restricted stock surrender (8) (8)          
Stock-based compensation 458 458          
Other comprehensive income (loss), net of tax 1,747     (257) 973 780 251
Balance at end of period at Sep. 30, 2018 228,155 474,221 (211,741) (18,075) (31,241) (716) 15,707
Statement of Consolidated Stockholders' Equity              
Impact of adoption of ASU 2018-02     2,931   (2,931)    
Net (loss) income (5,002)   (5,095)       93
Restricted stock surrender (20) (20)          
Stock-based compensation 402 402          
Dividends paid (390)           (390)
Other comprehensive income (loss), net of tax (4,778)     (1,787) (877) (1,591) (523)
Balance at end of period at Dec. 31, 2018 $ 218,367 $ 474,603 $ (213,905) $ (19,862) $ (35,049) $ (2,307) $ 14,887